US FDA inspects Divis Laboratories'
30 November -0001 | News | By BioSpectrum Bureau
US FDA inspects Divis Laboratories'
Divis Laboratories' Visakhapatnam facility was inspected by US FDA
The Unit II at village Chippada near Visakhapatnam has had an inspection by the United States Food and Drug Administration (USFDA) with no major observations, Divis Laboratories said.
"The audit concluded with one observation primarily about further improvement of existing procedure. The purpose of this inspection was for custom manufactured product," it added.
Divis undertakes custom manufacture of active pharmaceutical ingredients (APIs) and advanced intermediates.
